Skip to main content

Table 2 Clinical diagnosis and seroprevalence of anti-T. gondii IgG antibodies in 137 psychiatric patients.

From: Seroepidemiology of Toxoplasma gondiiinfection in psychiatric inpatients in a northern Mexican city

Clinical Diagnosis ICD-10 diagnosis Patients studied Patients with anti-T. gondii antibodies  
   No. % No. % P value*
Schizophrenia F20 38 27.7 10 26.3 0.005
Mental and behavioural disorders due to psychoactive substance use F14, F18–19 25 18.2 4 16 0.21
Mental disorder F06.2, F06.8–9 20 14.6 1 5 0.47
Mental retardation F71–73 19 13.9 4 21.1 0.1
Mental and behavioural disorders due to use of alcohol F10 14 10.2 2 14.3 0.38
Bipolar affective disorder F31 6 4.4 1 16.7 0.44
Epilepsy G40 4 3 0 0 0.69
Severe depressive episode F32.2–3 3 2.2 1 33.3 0.25
Dementia in Alzheimer's disease with early onset F00.0 2 1.5 2 100 0.009
Dissociative disorder F44 1 0.7 0 0 0.91
Vascular dementia F01 1 0.7 0 0 0.91
Somatoform disorder F45 1 0.7 0 0 0.91
Obsessive-compulsive disorder F42 1 0.7 0 0 0.91
Acute polymorphic psychotic disorder F23.1 1 0.7 0 0 0.91
Schizoaffective disorder, mixed type F25.2 1 0.7 0 0 0.91
All   137 100 25 18.2 0.02
  1. *As compared with 8.9% seroprevalence of anti-T. gondii IgG antibodies in controls (16/180).